A study with larger cohort seems mandatory to clarify whether the same role of FRAT1 exists in other histological subtypes of ovarian cancer, such as clear cell, endometrioid and mucinous adenocarcinomas. This evidence concerns the gene FRAT1 and ovarian carcinoma.